1. Hauptnavigation
  2. Navigation des Hauptbereiches
  3. Inhalt der Seite

Press Officer and Head of Press and Public Relations

Dr. Stefanie Seltmann
Dr. Stefanie Seltmann

Im Neuenheimer Feld 280
69120 Heidelberg

Phone: +49 6221 422854
Fax: +49 6221 422968

E-Mail: s.seltmann@dkfz.de
or presse@dkfz.de

Recent Press Releases

No. 65 | 16. December 2014 | by Ber

DKFZ awards Dr. Emil Salzer Prize und Richtzenhain Prize to tumor genetics researchers

DKFZ awards Dr. Emil Salzer Prize und Richtzenhain Prize to tumor genetics researchers

The German Cancer Research Center (DKFZ) has awarded the Dr. Emil Salzer Prize to Professor Roland Rad (Munich Technical University), whose research focuses on the basic genetic mechanisms underlying bowel cancer. Tumor genomes are also a focus of Professor Stefan Pfister (DKFZ and Heidelberg University) and Professor Roman Thomas (University of Cologne). The latter two scientists received this year’s sponsorship award from the Walther and Christine Richtzenhain Foundation. The award ceremony took place on December 16, 2014, at the DKFZ.

No. 63 | 08. December 2014 | by Koh

A yardstick to measure the malignancy of prostate cancer

A yardstick to measure the malignancy of prostate cancer

A protein that influences the epigenetic characteristics of tumor cells is directly linked to the grade of malignancy of prostate cancer. This key discovery has been made by a team of scientists from the German Cancer Research Center (DKFZ), the University of Zurich, Hamburg-Eppendorf University Hospital, Heidelberg University, and other institutes in a study of 7,700 samples of tumor tissue. The detection of this biomarker may serve as an indicator of the likelihood that the disease may take an aggressive course, and may thus be helpful in choosing an appropriate treatment. The study was part of the “Early Onset Prostate Cancer” project, supported by the Federal Ministry of Education and Research (BMBF) as part of the International Cancer Genome Consortium (ICGC).

No. 62 | 05. December 2014 | by Koh

A second chance for children with cancer

A second chance for children with cancer

Today most cases of childhood cancer can be cured. However, in about 20 percent of cases children suffer a recurrence of the cancer following therapy and they ultimately succumb to the disease. With a new project called INFORM*, scientists from the German Cancer Research Center (DKFZ) and the German Consortium for Translational Cancer Research (DKTK) aim to provide these children with a second avenue toward cures. The work is based on an analysis of the tumor's complete genetic information at the time of relapse. The data allows researchers to discover factors that promote tumor growth and investigate whether novel, targeted drugs can help cure the individual child’s disease. The goal is to identify genomic alterations in all cases of recurrent cancer in children across Germany and search for drugs that precisely target the tumor of each affected child. German Cancer Aid (Deutsche Krebshilfe) and the German Childhood Cancer Foundation (Deutsche Kinderkrebsstiftung) will now provide about €1.1 million to fund a two-year feasibility study.

Audio (in German only)
einblick (in German only)
Publications
Videos (in German only)
last update: 16/10/2013 back to top